Dear Friend of DKT,


We are pleased to share our 2022 sales and CYP results.


DKT International had a record-breaking 2022, as we delivered over 61.6 million CYPs across more than 100 countries, an increase of 14% over 2021 results. During a year marked by global inflation, conflict, and lingering supply chain issues, DKT offices around the world remained focused on ensuring that people could shape their reproductive destinies with the products, services, and information they choose.  


We are transparent with our results. A summary of our 2022 product and service results is detailed below, and a breakdown of sales by country and product is available on our website here. We believe sharing these figures helps the reproductive health community better understand market dynamics, how health needs are being met, and where gaps may still exist.


In addition to these sales figures, we are proud to share the following related results:

  

  • DKT’s partner, Women First Digital, netted 7.3 million site visits in 2022 across their three websites: howtouseabortionpill, safe2choose, and findmymethod
  • DKT WomanCare expanded product offerings and geographies, strengthening its role as a hand-in-glove partner with manufacturers for global distribution and marketing; and
  • carafem, DKT’s affiliate in the USA, provided services to more than 19,700 clients, expanding our telemedicine work by 185% over the prior year.
  • DKT further continued to expand work in challenging environments including Ukraine, Afghanistan, South Sudan, and Chad. Read more about our work, and the work of our partner in Ukraine, here
  • DKT trained and detailed over 455,800 providers on contraception and safe abortion methods in 2022.


Sincerely,


The DKT International Team

Product

2022 Sales

Total CYPs

61.6 million

Male condoms

1.01 billion

Female condoms

613,120

Oral contraception (OC)

107.8 million

Emergency contraception

24.6 million

IUDs

4 million

Contraceptive suppositories

1.3 million

Total injectables

34.3 million

3-month injectables

25.6 million

3-month injectable (SubQ)

270,550

2-month injectables

1.5 million

1-month injectables

6.6 million

Total implants

1.63 million

3-year implants

1.4 million

4-year implants

69,050

5-year implants

106,690

Tubal ligations and vasectomies

75,240

Mife/Miso combipacks

6.15 million

Mifepristone

51,400

Misoprostol

23.6 million

Manual Vacuum Aspirators (MVA) aspirators

314,920

MVA cannulae

2.2 million

Abortion services provided (in-clinic, telemedicine)

22,740

Other products

2022 Sales

Lubricants

7 million

Pregnancy test kits

3.8 million

Male enhancement supplements

3.3 million

Oral rehydration salts

2.5 million

Sildenafil (generic Viagra)

1.62 million

Feminine care products

449,510

HIV self-test kits

157,075

Lactation supplements

27,030





DKT is an innovative and adventurous social marketing organization that improves people's lives.


+1 202-223-8780

info@dktinternational.org


Donate to DKT
DKT Website
Facebook      LinkedIn      Twitter      Instagram
LinkedIn Share This Email